CME Group Announces New Leadership Roles
February 19 2010 - 12:10PM
PR Newswire (US)
CHICAGO, Feb. 19 /PRNewswire-FirstCall/ -- CME Group, the world's
leading and most diverse derivatives marketplace, today announced
the following changes to its Management Team to further serve its
global customer base: -- Bryan T. Durkin, who has served as Chief
Operating Officer since 2007, will now assume oversight of the
company's Products & Services Division in addition to his
current responsibilities. In his new role as Chief Operating
Officer and Managing Director, Products & Services, Durkin will
lead both the operations and sales functions for CME Group to focus
on increasing product line growth and meeting customer needs
worldwide. Durkin has nearly 30 years of industry experience,
including senior leadership positions at CME Group and The Chicago
Board of Trade. Durkin will continue to report to CME Group
President Phupinder Gill. -- Rick Redding, who previously led
Products & Services, has assumed a new planning role related to
CME Group's pending ownership stake in a new index services venture
with Dow Jones. Redding has an extensive background in equity
markets, having previously run the company's equity product line
for 10 years and forged strong relationships with all of its index
licensors. Together with Scot Warren, Managing Director, Equity
Products and Index Services, Redding will assist with the joint
venture formation and strategic planning process. Redding also will
work with Durkin for a transition period to ensure continuity in
the company's efforts to develop its core business, OTC products
and global sales force. Redding will assume the new role of
Managing Director, Products & Services Initiatives, and he will
report to Durkin. -- Kendal Vroman has been named Managing
Director, Commodity Products, OTC Services & Information
Products. Vroman most recently served as Managing Director &
Chief Corporate Development Officer and has worked in a number of
senior leadership roles at CME Group since 2001. In this role, he
will oversee the company's energy, agricultural and metals
commodities businesses. Laurent Paulhac, Managing Director, OTC
Products and Services will report to Vroman, as will the company's
information products business. Vroman will report to Durkin. Barry
Goldblatt, who previously held the role of Managing Director,
Commodities, Energy & Metals has resigned to pursue other
interests. -- Scot E. Warren has been promoted to a new role on the
company's management team as Managing Director, Equity Index
Products & Index Services with continued responsibility for the
company's equity product line, as well as additional responsibility
for the company's index services business. Warren previously served
as Managing Director, Equity Products and joined CME Group in 2007.
He will report to Durkin. -- James E. Parisi will assume expanded
responsibilities for the company's corporate development and
corporate strategy functions as Chief Financial Officer and
Managing Director, Finance & Corporate Development. Parisi
joined CME Group in 1988. He will continue to report to Donohue. In
addition, Jill A. Harley will assume an expanded role as Managing
Director, Corporate Finance Services while James V. Pieper will
assume the role of Managing Director & Chief Accounting Officer
previously held by Harley. Pieper will continue to report to
Harley, and Harley will continue to report to Parisi. -- John W.
Pietrowicz has been promoted to a new role on the company's
management team as Managing Director, Business Development &
Corporate Finance. Pietrowicz will have day-to-day oversight of and
responsibility identifying, negotiating, financing and managing
ongoing investments in new business opportunities. Pietrowicz
joined CME Group in 2003 and previously served as Managing Director
& Deputy Chief Financial Officer. He will continue to report to
Parisi. The company also announced that Sean Keating, Managing
Director, New York Operations will be assuming an expanded role as
Managing Director and Head of CME Group's New York office,
responsible for daily administration of New York operations. He
will continue to report to Julie Holzrichter, CME Group Managing
Director, Global Operations. As the world's leading and most
diverse derivatives marketplace, CME Group
(http://www.cmegroup.com/) is where the world comes to manage risk.
CME Group exchanges offer the widest range of global benchmark
products across all major asset classes, including futures and
options based on interest rates, equity indexes, foreign exchange,
energy, agricultural commodities, metals, weather and real estate.
CME Group brings buyers and sellers together through its CME Globex
electronic trading platform and its trading facilities in New York
and Chicago. CME Group also operates CME Clearing, one of the
largest central counterparty clearing services in the world, which
provides clearing and settlement services for exchange-traded
contracts, as well as for over-the-counter derivatives transactions
through CME ClearPort. These products and services ensure that
businesses everywhere can substantially mitigate counterparty
credit risk in both listed and over-the-counter derivatives
markets. The Globe logo, CME, Chicago Mercantile Exchange, CME
Group, Globex, E-mini and CME ClearPort are trademarks of Chicago
Mercantile Exchange Inc. CBOT and Chicago Board of Trade are
trademarks of the Board of Trade of the City of Chicago. NYMEX and
New York Mercantile Exchange are trademarks of New York Mercantile
Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. All
other trademarks are the property of their respective owners.
Further information about CME Group (NASDAQ:CME) and its products
can be found at http://www.cmegroup.com/. CME-G DATASOURCE: CME
Group CONTACT: Media, Laurie Bischel, +1-312-648-8698, or Anita
Liskey, +1-312-466-4613, , http://www.cmegroup.mediaroom.com/, or
Investors, John Peschier, +1-312-930-8491, all of CME Group Web
Site: http://www.cme.com/
Copyright
CME (NASDAQ:CME)
Historical Stock Chart
From Jun 2024 to Jul 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Jul 2023 to Jul 2024